Now showing items 1-1 of 1

    • A Trial of Lopinavir-Ritonavir in Adults Hospitalized with Severe Covid-19 

      Cao B et al. From the Department of Pulmonary and Critical Care Medicine, Center of Respiratory Medicine, National Clinical Research Center for Respiratory Diseases (2020-03-18)
      BACKGROUND: No therapeutics have yet been proven effective for the treatment of severe illness caused by SARS-CoV-2. METHODS: We conducted a randomized, controlled, open-label trial involving hospitalized adult patients ...